In a regulatory filing, Enovix disclosed that its director Thurman Rodgers bought 69.6K shares of common stock on March 20th in a total transaction size of $757.

In a regulatory filing, Snap disclosed that its COO Jerry Hunter sold 69.8K shares of common stock on March 16th in a total transaction size of $763.9K.

In a regulatory filing, Snap disclosed that its CFO Derek Andersen sold 49.2K shares of common stock on March 16th in a total transaction size of $539.2K.

In a regulatory filing, Broadcom disclosed that its CEO Hock Tan sold 30K shares of common stock on March 16th in a total transaction size of $18.8M.

RA Capital disclosed a 9.99% stake in Orchard Therapeutics, which represents over 18.56M shares. The filing does not allow for activism. Shares of Orchard Therapeutics are up 5.2% afterhours.

Canadian National announced that new tentative collective agreements have been reached between Unifor and CN. The collective agreements cover approximately 3,000 CN employees working in various departments such as Mechanical, Intermodal, Facility Management, and in clerical positions in Canada. No details of the tentative agreements will be released publicly until the agreements are ratified.

Moody's Investors Service assigned a Baa3 long-term issuer rating to Tesla and withdrew the Ba1 corporate family rating, the Ba1-PD probability of default rating, as well as the SGL-1 speculative grade liquidity rating. The outlook is stable. The rating action reflects Moody's expectation that "Tesla will remain one of the foremost manufacturers of battery electric vehicles with an expanding global presence and very high profitability." The upgrade also incorporates governance considerations, including Tesla's prudent financial policy and management's operational track record. Reference Link

In a regulatory filing, Charles Schwab disclosed that its director Gerri Martin-Flickinger bought bought 3.7K shares of common stock on March 17th in a total transaction size of $200.4K.

In a regulatory 8-K filing, the company states: "On March 2, 2023, SigmaTron Internationalreceived an Event of Default and Reservation of Rights from (i) J.P. Morgan Chase Bank, N.A. dated March 2, 2023 with respect to that certain Amended and Restated Credit Agreement dated as of July 18, 2022, by and among the Company, the other Loan Party thereto, and JPMorgan Chase Bank, N.A., as Lender, and (ii) TCW Asset Management Company, as Administrative Agent dated March 2, 2023 with respect to that certain Credit Agreement date of July 18, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the "Credit Agreement" and together with the Agreement the "Credit Agreements"), by and among the Company, WAGZ, Inc., a Delaware corporation, the financial institutions party thereto from time to time, and TCW Asset Management Company, as Administrative Agent for all Lenders. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Agreement and Credit Agreement, as applicable."

Nuance Communications, a Microsoft Company, announced Dragon Ambient eXperience or DAX Express, a workflow-integrated, fully automated clinical documentation application that is the first to combine proven conversational and ambient AI with OpenAI's newest and most capable model, GPT-4. Extending the proven Dragon Medical portfolio of solutions and building on the market-leading DAX ambient solution launched in 2020, DAX Express is the next milestone in Nuance's long-standing mission to reduce administrative burden and empower clinicians to spend more time taking care of patients and less time on paperwork. .. Using a unique combination of conversational, ambient, and generative AI, DAX Express automatically and securely creates draft clinical notes in seconds for immediate clinical review and completion after each patient visit in the exam room or via telehealth patient conversations. Clinicians will benefit from the seamless capabilities of Dragon Medical One, DAX, and DAX Express, which are tightly integrated into the electronic medical record, beginning from pre-visit through post-encounter, reducing cognitive burdens and helping increase the joy of practicing medicine. "Nuance and Microsoft came together with the goal of helping to digitally transform healthcare, and we are marking the next step forward in the ongoing evolution of AI-powered solutions for overburdened care providers," said Mark Benjamin, CEO of Nuance. "We've taken the power and advanced reasoning capabilities of GPT-4 and integrated it into our proven outcomes-focused AI technologies in a tested and responsible way. Our state-of-the-art blend of conversational, ambient, and generative AI will accelerate the advancement of the care delivery ecosystem beyond what Nuance or Microsoft could have achieved separately - expanding our comprehensive portfolio of solutions that fulfill our vision to improve care quality and support enhanced outcomes for generations to come." Reference Link